Baseline prognostic predictors in classical Hodgkin Lymphoma: a retrospective, single-center analysis on patients treated with PET/CT-guided ABVD
Although the IPS was still able to identify a subgroup of high-risk patients within our cohort of individuals treated with PET/CT-guided ABVD, not all the risk factors that it considers were found to have an impact on survival times. Moreover, by selecting only the significant IPS items and considering a more recently proposed prognostic factor (LMR) we were able to better identify patients at higher risk of relapse, in an effort to contribute to the building of a modern risk prediction tool that can help guide treatment choices.
Authors
- Chiara Adele Cavarretta (ORCID: https://orcid.org/0000-0002-5757-5687)
- Livio Trentin (ORCID: https://orcid.org/0000-0003-1222-6149)
- Valeria Ruocco
- Alessandro Cellini (ORCID: https://orcid.org/0000-0003-1094-9992)
- Andrea Visentin (ORCID: https://orcid.org/0000-0003-0271-7200)
- Filippo Crimì (ORCID: https://orcid.org/0000-0001-6822-1430)
- Federica Alessandra Vianello (ORCID: https://orcid.org/0000-0001-7801-5825)
- Francesco Piazza (ORCID: https://orcid.org/0000-0002-2831-623X)
- Francesco Angotzi (ORCID: https://orcid.org/0000-0001-7835-2573)
- Marco Pizzi (ORCID: https://orcid.org/0000-0003-4006-7317)
- Stefania Vio
- Michele Gregianin
- Nicolò Danesin (ORCID: https://orcid.org/0009-0004-1352-306X)
- Andrea Serafin
Institutions
- University of Padua (IT)
- Istituto Oncologico Veneto (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-09-05
- DOI
- https://doi.org/10.3389/fonc.2024.1419118
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00